STOCKS TO BUY: We have identified several stocks that can potentially TRIPLE. Learn more!

Global Contact Lenses And Solutions Industry

Advanced EyeCare Carries CIBA Vision's New Contact Lens

Technology II-48

RevolutionEYES Offers New Bifocal Contact Lens II-48

Alcon Unveils Opti-Free GP Contact Lens Solution II-48

UltraVision Introduces UltraWave® SiH II-49

Contamac Introduces New GP Contact Lens Materials II-49

Art Optical Introduces New Thinsite2 Lens II-49

CooperVision Launches New Biofinity Toric Lens II-49

Alcon Unveils +3.0 Add Power AcrySof® ReSTOR® Aspheric

Intraocular Lens II-49

Bausch & Lomb Launches Crystalens® HD Intraocular Lens II-50

Unilens Vision Rolls Out C-VUE® Advanced™ Custom Toric Lens II-50

Unilens Vision Unveils C-VUE 1 Day Aspheric Single Vision

Contact Lens II-50

CooperVision Extends Parameters of Proclear® 1-Day Contact Lenses II-50

CooperVision Extends Sphere Powers of Proclear® Sphere Contact

Lenses II-51

CooperVision Extends Parameters of Biofinity® Silicone

Hydrogel Contact Lenses II-51

Bausch & Lomb to Introduce SofLens® Daily Disposable Contact

Lenses II-51

UltraVision to Unveil KeraSoft®IC Lenses II-52

Bausch & Lomb to Introduce SofLens® Daily Disposable Contact

Lenses II-52

UltraVision to Unveil KeraSoft®IC Lenses II-52

Bausch & Lomb to Introduce SofLens® Daily Disposable Contact

Lenses II-53

UltraVision to Unveil KeraSoft®IC Lenses II-53

Bausch & Lomb to Introduce SofLens® Daily Disposable Contact

Lenses II-54

UltraVision to Unveil KeraSoft®IC Lenses II-54

Alcon Receives FDA Approval for AcrySof® IQ ReSTOR®

Intraocular Lens II-54

Bausch & Lomb Secures Approval for Akreos™ Advanced Optics

Aspheric Lens II-55

CooperVision Secures FDA Approval for Biofinity® Silicone

Hydrogel Contact Lenses II-55

Hoya Surgical Optics Wins Approval for iSpheric™ Model YA-60BB

Intraocular Lens II-55

SynergEyes Inc. Unveils Post-Surgical Hybrid Contact Lens II-55

5. RECENT INDUSTRY ACTIVITY II-56

Bruno Pharmaceuticals Takes Over Safilens® II-56

WellPoint to Take Over 1-800 CONTACTS II-56

OcuSoft Inks Agreement with Essentia Pharma II-56

Essilor International Takes Over Majority Stake in Jiangsu

Youli Optics and Jiangsu Seeworld Optical II-56

Menicon Acquires W.I. System II-56

Alcon Merges Operations with Novartis II-57

GP Specialists Takes Over American BioCurve™ II-57

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
TRY IT FREE
New! $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,318.23 138.38 0.91%
NASDAQ 3,482.18 30.05 0.87%
S&P 500 1,651.81 12.77 0.78%
US 10 Yr 2.182% +0.011

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs